Xing Xiaoxiao, Li Junyi, Fan Yangyang, Wang Yun, Wang Yue, Liao Daixiang, Zhang Shiyun
Department of Surgery, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
Department of Radiology, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
Front Oncol. 2025 Mar 4;15:1548036. doi: 10.3389/fonc.2025.1548036. eCollection 2025.
High-grade adenosquamous carcinoma (HGASC) is a rare and aggressive subtype of metaplastic breast cancer (MpBC). This article reports a case of HGASC (pT2N0M0 Stage IIA) in a 43-year-old female and reviews the relevant literature, with a specific focus on distinguishing HGASC from other MpBC subtypes, particularly low-grade adenosquamous carcinoma (LGASC). The patient underwent a skin-sparing mastectomy with abdominal rectus myocutaneous flap reconstruction. Histopathology confirmed HGASC with metaplastic features. Postoperative adjuvant chemotherapy with capecitabine was administered. The case highlights the unique clinical, imaging, and pathological characteristics of HGASC, its therapeutic challenges, and the need for individualized treatment strategies. A five-month follow-up showed no signs of recurrence or metastasis.
高级别腺鳞癌(HGASC)是化生性乳腺癌(MpBC)中一种罕见且侵袭性强的亚型。本文报告了一例43岁女性的HGASC(pT2N0M0 ⅡA期)病例,并回顾相关文献,特别着重于将HGASC与其他MpBC亚型,尤其是低级别腺鳞癌(LGASC)相鉴别。该患者接受了保留皮肤的乳房切除术及腹直肌肌皮瓣重建术。组织病理学证实为具有化生特征的HGASC。术后给予了卡培他滨辅助化疗。该病例突出了HGASC独特的临床、影像学及病理特征、其治疗挑战以及个体化治疗策略的必要性。五个月的随访显示无复发或转移迹象。